Law360, New York (May 29, 2009, 12:00 AM ET) -- Centocor Ortho Biotech Inc.'s new rheumatoid arthritis drug Simponi can cause severe and potentially fatal fungal infections, according to the U.S. Food and Drug Administration, marking the latest medication in a class of drugs known as tumor necrosis factor alpha blockers to come under scrutiny in recent months.
The FDA posted the warning on its Web site Wednesday along with a "Dear Healthcare Professional" letter that has been issued by Horsham, Pa.-based Centocor in order to warn doctors of the risk of serious fungal infections associated...
Centocor's Simponi May Cause Fatal Infections: FDA
To view the full article, take a free trial now.
